iKang Healthcare Group (KANG) Downgraded by BidaskClub to Strong Sell

BidaskClub cut shares of iKang Healthcare Group (NASDAQ:KANG) from a sell rating to a strong sell rating in a research note issued to investors on Wednesday.

Separately, TheStreet cut shares of iKang Healthcare Group from a c rating to a d+ rating in a research report on Wednesday, August 15th.

NASDAQ KANG traded down $0.40 on Wednesday, hitting $15.90. The stock had a trading volume of 36,019 shares, compared to its average volume of 84,305. iKang Healthcare Group has a one year low of $14.21 and a one year high of $21.01. The company has a current ratio of 0.71, a quick ratio of 0.69 and a debt-to-equity ratio of 0.08. The stock has a market cap of $1.19 billion, a price-to-earnings ratio of 59.21 and a beta of 0.12.

iKang Healthcare Group (NASDAQ:KANG) last posted its earnings results on Thursday, September 27th. The medical research company reported $0.09 EPS for the quarter. iKang Healthcare Group had a negative net margin of 2.44% and a positive return on equity of 5.22%. The firm had revenue of $150.24 million during the quarter.

A number of hedge funds and other institutional investors have recently bought and sold shares of KANG. BlueMountain Capital Management LLC bought a new position in shares of iKang Healthcare Group in the second quarter valued at approximately $130,944,000. Millennium Management LLC boosted its holdings in shares of iKang Healthcare Group by 338.9% in the second quarter. Millennium Management LLC now owns 1,298,279 shares of the medical research company’s stock valued at $26,563,000 after acquiring an additional 1,002,461 shares in the last quarter. State of Wisconsin Investment Board boosted its holdings in shares of iKang Healthcare Group by 279.3% in the second quarter. State of Wisconsin Investment Board now owns 293,871 shares of the medical research company’s stock valued at $6,013,000 after acquiring an additional 216,396 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in shares of iKang Healthcare Group by 477.6% in the second quarter. Renaissance Technologies LLC now owns 257,360 shares of the medical research company’s stock valued at $5,266,000 after acquiring an additional 212,800 shares in the last quarter. Finally, City Financial Investment Co Ltd boosted its holdings in shares of iKang Healthcare Group by 302.8% in the third quarter. City Financial Investment Co Ltd now owns 246,482 shares of the medical research company’s stock valued at $4,461,000 after acquiring an additional 185,291 shares in the last quarter. Hedge funds and other institutional investors own 52.13% of the company’s stock.

About iKang Healthcare Group

iKang Healthcare Group, Inc, together with its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. It operates in two segments, Medical Examinations, and Other Medical Services and Dental Services. The company offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab test, electrocardiogram, ultrasound, and X-ray examination items.

Further Reading: Cash Flow

Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply